Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects and Feasibility of Photobiomodulation at 830 Nanometers in the Treatment of Diabetic Ulcers: a Randomized, Double-blind Clinical Trial

NCT07043868 is registered in ClinicalTrials.gov with Federal University of Piaui as lead sponsor.

NCT NCT07043868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07043868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects and Feasibility of Photobiomodulation at 830 Nanometers in the Treatment of Diabetic Ulcers: a Randomized, Double-blind Clinical Trial
Lead sponsor
Federal University of Piaui
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 10, 2026
Completion date
January 10, 2028
Enrollment
136 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, diabetic foot ulcer, low level laser therapy, photobiomodulation